Abstract:To investigate the evolution of pulmonary hypertension induced by intratracheal bleomycin (BLM) in immature rabbits.Immature rabbits were divided into control and BLM groups. Two and four weeks after intratracheal normal saline or BLM, the systolic, diastolic and mean pulmonary artery pressure (PASP, PADP, MPAP) were measured by micro-catheter, the pathological changes and the expression of VEGFmRNA and eNOSmRNA of endothelial cells in pulmonary arteries were evaluated by HE and in situ hybridization.Pulmonary artery pressure was elevated 2 weeks and 4 weeks after intratracheal BLM. Two weeks after treatment PASP was (16.5 +/- 2.9 compared with 25.2 +/- 7.0) mmHg, PADP (8.8 +/- 4.2 compared with 13.1 +/- 3.8) mmHg, MPAP (12.1 +/-4.0 compared with 18.4 +/-4.7) mmHg in control and BLM groups, respectively; meanwhile 4 weeks after treatment, PASP was (16.7 +/-2.3 compared with 23.8 +/-7.1) mmHg, PADP (7.3 +/-1.5 compared with 13.8 +/-6.6) mmHg, MPAP (11.3 +/- 1.9 compared with 17.6 +/- 6.3) mmHg in control and BLM groups, respectively. The thickness of arterial wall increased and the cavity became narrow, and the thickness index (TI) and area index (AI) increased in middle and small pulmonary arteries 2 weeks and 4 weeks after intratracheal BLM. Two weeks after treatment TI was 0.52 +/- 0.16 compared with 0.65 +/- 0.16, AI 0.74+/- 0.17 compared with 0.84 +/- 0.14 in control and BLM groups, respectively; meanwhile 4 weeks after treatment TI was 0.52 +/- 0.11 compared with 0.64 +/- 0.15, AI 0.71 +/- 0.15 compared with 0.85 +/- 0.10 in control and BLM groups. The levels of VEGFmRNA and eNOSmRNA expression in pulmonary arterial endothelial cells decreased 2 weeks and 4 weeks after intratracheal BLM. Two weeks after treatment VEGFmRNA was 0.83 +/- 0.09 compared with 0.45 +/- 0.11, eNOSmRNA 0.79 +/- 0.12 compared with 0.45 +/- 0.12 in control and BLM groups, respectively; meanwhile 4 weeks after VEGFmRNA was 0.81 +/- 0.19 compared with 0.46 +/- 0.15, eNOSmRNA 0.89 +/- 0.14 compared with 0.44 +/- 0.12 in control and BLM groups, respectively.Intratracheal bleomycin may induce the pathological changes of pulmonary arteries and decrease the expression of VEGFmRNA and eNOSmRNA in immature rabbits, which results in pulmonary hypertension.

[Relationship Between Bleomycin-Induced Pulmonary Fibrosis and Vascular Endothelial Cell Injury].

Gene Transfer of Vascular Endothelial Growth Factor Reduces Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits.

VEGFmRNA and Enosmrna Expression in Immature Rabbits with Bleomycin-Induced Pulmonary Hypertension.

Pathophysiology of bleomycin-induced pulmonary hypertension in immature rabbits]

[Effect of VEGF Gene Transfer on the Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits].

Expression and Action of Phosphodiesterase 4B in Bleomycin-Induced Pulmonary Fibrosis in Mice

Proliferative phenotype of pulmonary microvascular endothelial cells plays a critical role in the overexpression of CTGF in the bleomycin-injured rat.

[Changes of Tight Junction and Cx43 Expression in Microvessel Endothelial Cells of Mouse Lung Induced by Bleomycin].

Particulate matter with a diameter of ≤2.5 μm induces and enhances bleomycin-induced pulmonary fibrosis by stimulating endoplasmic reticulum stress in rat.

[Effects of Sense Vascular Endothelial Growth Factor Cdna Transfection on Mononuclear Chemotaxis Protein-1 Expression in Rat Pulmonary Microvessel Endothelial Cells].

Expression of Tgf-Beta(1), Pdgf and Igf-1 Mrna in Lung of Bleomycin-A(5)-Induced Pulmonary Fibrosis in Rats

Bleomycin induces epithelial-to-mesenchymal transition via bFGF/PI3K/ESRP1 signaling in pulmonary fibrosis.

[Effect of Interferon-Gamma on Bleomycin Induced Pulmonary Fibrosis in Rats].

Change of [ca~(2+)]i in Microvessel Endothelial Cells from Rats with Pulmo-Nary Fibrosis and Its Related Mechanism

Pathologic Alterations in Lung Injury and Pulmonary Fibrosis Induced by Endotoxin and Bleomycin

Preventive Effects of Vitamin D Treatment on Bleomycin-Induced Pulmonary Fibrosis

Angiogenesis in experimental pulmonary pulmonary fibrosis

The changes of pulmonary interstitial cells during bleomycin-induced lung fibrosis in rats

Hypoxia-Induced Epithelial-Mesenchymal Transition is Involved in Bleomycin-Induced Lung Fibrosis

Expressions of IGF- Ⅰ and TGF-β1 in Rats with Pulmonary Fibrosis

Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats